Global Needle Free Injection Market Report 2019 Based on Synthesis and Analysis by Clinical Aspects
Global Needle Free Injection Market Research Report information: Product (Fillable) Technology (Jet-Based) Usability (Reusable), Type of Medication (Liquid-Based), Site of Delivery (Intra dermal), Application (Vaccination) End Users (Hospitals) – Forecast Till 2023
Market Highlights:
The global needle free
injection market size is expected to touch USD
25,057.4 million by 2023 owing to high prevalence of diabetes and chronic
diseases. Market Research Future’s (MRFR) latest study reveals that the market
is predicted a 15.28 % CAGR during the forecast period (2018–2023). Needle free
injections are medical devices which deliver drugs directly via the skin instead
of using hypodermic needles as a medium. High demand for needle free injectors
in home healthcare in North America and Europe is expected to augur market
growth. In addition, rising investments in biopharmaceuticals are expected to
provide the market a much-needed impetus.
Awareness among patients
regarding benefits of needle free injections is anticipated to prevent reuse of
needles and reduce the probability of contamination. Increasing use of these
injections by patients owing to its accurate dosage, pain relief, and low risks
can lead to high market demand in the coming years. But high costs of these
medical devices can pose a challenge to market growth.
Avail
a Free Sample@ https://www.marketresearchfuture.com/sample_request/6180
Global Market for Needle Free Injection –
Segmental Analysis
MRFR’s report offers a detailed segmental analysis of
the market based on product, technology, usability, type of medication, site of
delivery, application, and end-user. By product type, the market has been
segmented into fillable and prefilled needle free injectors. The fillable
segment is expected to be the biggest product till 2023, with the syringe being
beneficial to the practitioner, with the vaccine filled according to the
disease. Technologies covered in the report include laser-powered, jet-based,
and spring-based. Among these, the jet-based segment can touch a size of USD
10,391.3 million by 2023 owing to a faster method of delivery as compared to
other technologies. By usability, the market is segmented into reusable and
disposable. The reusable segment is expected to register a 15.90% CAGR over the
forecast period.
By type of medication, the market is segmented into
projectile/depot-based, powder-based, and liquid-based. The liquid-based
segment held a large share of the market in 2017. It can continue to dominate
till 2023 owing to its easy working mechanism. By site of medication, the
market is segmented into intradermal, intramuscular, and subcutaneous
injectors. The intramuscular segment is touted to generate maximum revenue for
the needle free injection market owing to muscles absorbing vaccines at a much
higher rate as compared to veins.
Applications include oncology, vaccination, and
insulin delivery. The insulin delivery segment is projected to expand at a
14.9% CAGR over the forecast period fueled by large pool of diabetics demanding
a pain-free solution for receiving insulin. Major market end-users include
hospitals and clinics, ambulatory surgical centers, and homecare settings. The
hospitals and clinics segment is projected to generate maximum revenue for the
market by 2023 owing to high demand for sophisticated devices to deliver
vaccines for chronic diseases.
Regional
Outlook
The needle
free injection market, on the basis of region, is segmented into the Americas,
Europe, Asia Pacific (APAC), and the Middle East and Africa (MEA). The Americas
are expected to dominate the global market owing to prevalence of chronic diseases
and demand for self-administrative devices. Technological breakthroughs in
pharmaceutical and biotechnology sectors, investments by industry participants,
and high awareness among patients are factors anticipated to fuel market growth
over the forecast period.
Europe is
expected to register a significant growth rate over the forecast period due to
the presence of well-established healthcare infrastructure and huge patient
pool.
The APAC
needle free injection market is projected to showcase a robust CAGR over the
forecast period owing to strong economies of India and China. Increased
healthcare expenditures of these developing economies coupled with a large
patient pool can spur market demand. Enhanced safety and quality standards
adhered by manufacturers of these medical devices can culminate in remarkable
product sales.
The MEA market commands a smaller market share
compared to others owing to stringent government policies and less emphasis on
healthcare expenditure.
Analysis Period
- Base
Year - 2017
- Projection
Period - From 2018 to 2023
- Market
Denomination - USD Million
- Conversion
Rate - Considered as per the respective financial years
Intended Audience
- Government
Research Institutes
- Research
and Development (R&D) Companies
- Medical
Devices Companies
- Academic
Institutes and Universities
For the scope of research, the report offers a
comprehensive analysis of the global needle free injection market.
Access Report Details @ https://www.marketresearchfuture.com/reports/needle-free-injection-market-6180
The report for Global market by Market
Research Future comprises of extensive primary research along with the detailed
analysis of qualitative as well as quantitative aspects by various industry
experts, key opinion leaders to gain a deeper insight of the market and
industry performance. The report gives a clear picture of the current market
scenario which includes past and estimated future market size with respect to
value and volume, technological advancement, macro economical and governing
factors in the market. The report provides detail information about and
strategies used by top key players in the industry. The report also gives a
broad study of the different market segments and regions.
Global Market for Needle
Free Injection – Competitive Dashboard
Some of the key players
profiled in the market report PenJet Corporation, European Pharma Group, Endo
Pharmaceuticals Inc., PharmaJet, Inc., National Medical Products Inc., INJEX
Pharma GmBH, Valeritas Holdings, Inc., CROSSJECT, Antares Pharma Inc., MIKA
MEDICAL CO., Inovio Pharmaceuticals Inc., Medical International Technology,
Inc., and D'Antonio Consultants International, Inc. Investments in research and
development and launch of new products are strategies employed by these players
to acquire a larger market share.
TOC:
1.
Report Prologue
2. Market
Introduction
2.1
Definition
2.2 Scope of the
Study
2.2.1
Research Objective
2.2.2
Assumptions
2.2.3
Limitations
3. Research
Methodology
3.1 Introduction
3.2 Primary
Research
3.3 Secondary research
3.4 Market Size
Estimation
TOC…Continued
Ask
Questions to Expertise @ https://www.marketresearchfuture.com/enquiry/6180
About Market Research Future:
At Market Research Future (MRFR), we enable our
customers to unravel the complexity of various industries through our Cooked
Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research
Reports (3R), Continuous-Feed Research (CFR), and Market Research &
Consulting Services.
MRFR team have supreme objective to provide the
optimum quality market research and intelligence services to our clients. Our
market research studies by Components, Application, Logistics and market
players for global, regional, and country level market segments, enable our
clients to see more, know more, and do more, which help to answer all their
most important questions.
In order to stay updated with technology and work
process of the industry, MRFR often plans & conducts meet with the industry
experts and industrial visits for its research analyst members.
Contact Us:
Market
Research Future
Office
No. 528, Amanora Chambers
Magarpatta
Road, Hadapsar,
Pune
- 411028
Maharashtra,
India
Phone: +1 646 845 9312
Comments
Post a Comment